Napredna pretraga

Pregled bibliografske jedinice broj: 797240

Is there a relationship between hypomagnesemia and proton-pump inhibitors in patients on chronic hemodialysis?


Mikolašević, Ivana; Milić, Sandra; Štimac, Davor; Zaputović, Luka; Lukenda Žanko, Vesna; Gulin, Tonko; Jakopčić, Ivan; Klarić, Dragan; Gulin, Marijana; Orlić, Lidija
Is there a relationship between hypomagnesemia and proton-pump inhibitors in patients on chronic hemodialysis? // European journal of internal medicine, 30 (2016), 99-103 doi:10.1016/j.ejim.2016.01.026 (međunarodna recenzija, članak, znanstveni)


Naslov
Is there a relationship between hypomagnesemia and proton-pump inhibitors in patients on chronic hemodialysis?

Autori
Mikolašević, Ivana ; Milić, Sandra ; Štimac, Davor ; Zaputović, Luka ; Lukenda Žanko, Vesna ; Gulin, Tonko ; Jakopčić, Ivan ; Klarić, Dragan ; Gulin, Marijana ; Orlić, Lidija

Izvornik
European journal of internal medicine (0953-6205) 30 (2016); 99-103

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
Proton-pump inhibitors; serum magnesium; chronic hemodialysis

Sažetak
We investigated the association among long- term proton-pump inhibitors (PPIs) use with serum magnesium (Mg) levels in chronic hemodialysis (HD) patients, as well as possible association among PPIs use and increased risk of cardiovascular (CVD) morbidity in HD patients. Of 418 HD patients that were screened for inclusion, 136 were excluded due to incomplete medical data, duration of renal replacement therapy (RRT) for less than 12 months, use of Mg-based-phosphate binders or other Mg-based medications or either to presence of chronic increased GI losses. Among 282 patients included in the study, 170 patients were on PPIs. Serum Mg levels were significantly lower among PPI users vs. non-users (0.94±0.2vs.1.03±0.2 mmol/L ; p<0.0001). The median duration of PPIs use was 27±9.6 months (range from 12 to 108) and it was not significantly associated with Mg levels (r=0.116 ; p=0.167). Additionally, residual renal function didn’t show significant correlation with Mg concentration (r=-0.102 ; p=NS) in both groups of patients. The use of PPIs was an independent and strong predictor of low Mg concentrations even in multivariate analysis (OR 3.05 ; 95%Cl 1.2498- 7.4594, p=0.01). On the other hand, the daily dose of PPIs was not associated with low Mg levels. PPIs users had higher rate of adverse CVD events during the one year of follow-up in comparison to non-PPIs users but that difference wasn’t statistically significant (17.6%vs.10.7% ; p=0.110). We have found a significant association between PPIs use and lower serum Mg levels in chronic HD patients.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA


Ustanove
Medicinski fakultet, Rijeka,
Opća bolnica Zadar,
KBC "Sestre Milosrdnice",
Opća bolnica Šibenik,
Opća bolnica "Dr. Josip Benčević",
Klinički bolnički centar Rijeka

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus


Citati